Basics |
Stoke Therapeutics, Inc.
|
IPO Date: |
June 17, 2019 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$1.9B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.65 | 3.30%
|
Avg Daily Range (30 D): |
$0.77 | 2.79%
|
Avg Daily Range (90 D): |
$0.50 | 2.53%
|
Institutional Daily Volume |
Avg Daily Volume: |
.31M |
Avg Daily Volume (30 D): |
1.06M |
Avg Daily Volume (90 D): |
.8M |
Trade Size |
Avg Trade Size (Sh.): |
76 |
Avg Trade Size (Sh.) (30 D): |
69 |
Avg Trade Size (Sh.) (90 D): |
66 |
Institutional Trades |
Total Inst.Trades: |
1,246 |
Avg Inst. Trade: |
$1.92M |
Avg Inst. Trade (30 D): |
$3.09M |
Avg Inst. Trade (90 D): |
$2.44M |
Avg Inst. Trade Volume: |
.12M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.6M |
Avg Closing Trade (30 D): |
$4.2M |
Avg Closing Trade (90 D): |
$2.52M |
Avg Closing Volume: |
94.23K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$.91
|
$-.4
|
$1.95
|
Diluted EPS
|
$.86
|
$-.4
|
$1.9
|
Revenue
|
$ 199.89M
|
$ 13.82M
|
$ 158.57M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ 52.48M
|
$ -23.48M
|
$ 112.88M
|
Operating Income / Loss
|
$ 40.28M
|
$ -27.3M
|
$ 111.24M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -91.78M
|
$ -173.35M
|
$ 146.83M
|
PE Ratio
|
36.35
|
|
|
Splits |
Jun 06, 2019:
10:99
|
|
|
|